{"id":"W2072298846","doi":"10.1097/wco.0000000000000202","title":"Established disease-modifying treatments in relapsing-remitting multiple sclerosis","year":2015,"lang":"en","type":"review","venue":"Current Opinion in Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"U.S. Food and Drug Administration","keywords":"Teriflunomide; Fingolimod; Natalizumab; Glatiramer acetate; Tolerability; Medicine; Multiple sclerosis; Relapsing remitting; Dimethyl fumarate; Disease; Intensive care medicine; Adverse effect; Internal medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009296949,0.0007816718,0.002983041,0.001489364,0.0001004084,0.00004739668,0.0004082426,0.0004204068,0.00003024903],"category_scores_gemma":[0.004273925,0.0006636194,0.0004688452,0.001198422,0.0002294227,0.0001604687,0.0006180492,0.002068651,0.00008869255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006043125,"about_ca_system_score_gemma":0.0007299908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007425189,"about_ca_topic_score_gemma":0.00001653329,"domain_scores_codex":[0.9941558,0.001122936,0.00149293,0.001404522,0.0007032671,0.001120578],"domain_scores_gemma":[0.9968081,0.001168949,0.000470084,0.0008625693,0.000154343,0.0005359307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002765097,0.0008129892,0.04403559,0.02117121,0.00008245467,0.00003266194,0.0001347268,0.00001394675,8.088538e-7,0.000006476183,0.002936939,0.9304957],"study_design_scores_gemma":[0.005228297,0.0002843799,0.03218697,0.04593577,0.0002144561,0.00002191613,0.00001347126,0.0006603929,8.590631e-8,0.00001773349,0.9149647,0.0004718514],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007363814,0.9904225,0.00000544864,0.0002442139,0.005275074,0.002983062,0.0001070578,0.00009759414,0.0001285924],"genre_scores_gemma":[0.0006650191,0.996578,0.00005916017,0.00002861982,0.0006831817,0.001154566,0.0006833206,0.0001221709,0.00002599516],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9300238,"threshold_uncertainty_score":0.9995815,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4128435624167878,"score_gpt":0.4578714330300615,"score_spread":0.04502787061327373,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}